Results 111 to 120 of about 88,938 (144)

A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use. [PDF]

BMC Res Notes, 2016
Chiu MH, Al-Majed NS, Stubbins R, Pollmann D, Sandhu RK.   +4 more
europepmc   +1 more source

Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT). [PDF]

Int J Chron Obstruct Pulmon Dis, 2018
Beeh KM, Emirova A, Prunier H, Santoro D, Nandeuil MA.   +4 more
europepmc   +1 more source

The precision bronchodilator therapy in airflow limitation with asthma defining reversibility: An appraisal through pharmaco-responsiveness-based real-world observation. [PDF]

Lung India
Bhattacharyya P, Sen S, Ghosh S, Kar A.
europepmc   +1 more source

Utilization Patterns of Nebulized Glycopyrronium in Patients Hospitalized for Acute Exacerbations of Obstructive Airway Disease (AEOAD)-Indian Expert Perspectives. [PDF]

Adv Respir Med
Khanna A, Waghray P, Singh AK, Mehta J, Rithik, Bhagat S, Patil S, Barkate H.   +7 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Response to Letter]. [PDF]

Int J Chron Obstruct Pulmon Dis
Cherian M, Suissa S.
europepmc   +1 more source

Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Rebordosa C, Aguado J, Bartsch J, Saigi-Morgui N, Carsin AE, Garcia-Esteban R, Ignatova E, Freedman D, Perez-Gutthann S, Rivero-Ferrer E.   +9 more
europepmc   +1 more source

Hyperhidrosis: Prevalence, Diagnosis, and Stepwise Treatment. [PDF]

Dtsch Arztebl Int
Schreiner W, Rapprich S, Rzany B, Wiegering A.   +3 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol Single-Inhaler Triple Therapies for COPD: Real-World Observational Study [Letter]. [PDF]

Int J Chron Obstruct Pulmon Dis
Wedzicha JA, Kiran A.
europepmc   +1 more source

Analysis of Current Status and Influencing Factors of Inhaler Treatment Adherence Among COPD Patients. [PDF]

Int J Chron Obstruct Pulmon Dis
Jin Z, Ba B, Zhang W, Yang Z, Wang X.
europepmc   +1 more source

Verification of Budesonide/Glycopyrronium/Formoterol (BGF) Triple Therapy in the Department of Cardiology: A Pilot Study. [PDF]

Cureus
Kamihara T, Kaneko S, Omura T, Murohara T, Shimizu A.   +4 more
europepmc   +1 more source